Wird geladen...
Cystatin C as a biomarker of chronic kidney disease: latest developments
INTRODUCTION: Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well-demonstrated in the literature. Therefore, augmenting clinica...
Gespeichert in:
| Veröffentlicht in: | Expert Rev Mol Diagn |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7657956/ https://ncbi.nlm.nih.gov/pubmed/32450046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737159.2020.1768849 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|